Cohort 1 (conventional delivery room)a | Cohort 2 (new concept of delivery room)a, b | p | |
---|---|---|---|
Number of neonates | 56 | 50 | - |
Clinical characteristics | |||
Body birth weight, g | 1114 ± 285 | 1033 ± 315 | 0.066 |
Gestational age, w | 28 ± 0.3 | 28 ± 0.5 | 0.480 |
Caesarean section, n (%) | 50 (89) | 46 (92) | 0.746 |
Twins, n (%) | 14 (25) | 18 (36) | 0.192 |
Male, n (%) | 29 (52) | 22 (44) | 0.423 |
Apgar at 1 min | 5 ± 0.2 | 5 ± 0.1 | 0.850 |
Apgar at 5 min | 7 ± 0.1 | 7 ± 0.2 | 0.430 |
Prenatal corticosteroids, n (%) | 32 (58) | 22 (44) | 0.146 |
Surfactant therapy, n (%) | 40 (71) | 42 (84) | 0.123 |
Indications for preterm delivery | |||
Spontaneous preterm labour | 40 | 37 | 0.767 |
Preterm premature rupture of membranes | 8 | 6 | 0.422 |
Hypertensive disorders of pregnancy | 6 | 5 | 0.904 |
Intrauterine growth restriction | 2 | 2 | 0.908 |
Resuscitation interventions at birth | |||
Oxygen therapy, n (%) | 53 (95) | 45 (90) | 0.471 |
Positive pressure ventilation with face mask, n (%) | 23 (41) | 25 (50) | 0.357 |
Intubation, n (%) | 34 (61) | 29 (58) | 0.776 |
Drug administration, n (%) | 1 (2) | 2 (4) | 0.610 |
Chest compression, n (%) | 4 (7) | 2 (4) | 0.679 |
Nasal-CPAP in delivery room | 10 (17.9) | 9 (18.0) | 0.985 |
Nasal-CPAP without interruption during the first 30’ after birthc | 0 (0.0) | 9 (18) | 0.001 |